Cargando…
Targeting CD24 as a novel immunotherapy for solid cancers
Cluster of differentiation 24 (CD24), a mucin-like highly glycosylated molecule has been extensively studied as a cancer stem cell marker in a variety of solid cancers. The functional role of CD24 is either fulfilled by combining with ligands or participating in signal transduction, which mediate th...
Autores principales: | Yang, Yan, Zhu, Guangming, Yang, Li, Yang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623753/ https://www.ncbi.nlm.nih.gov/pubmed/37919766 http://dx.doi.org/10.1186/s12964-023-01315-w |
Ejemplares similares
-
CD24: A Novel Target for Cancer Immunotherapy
por: Panagiotou, Emmanouil, et al.
Publicado: (2022) -
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
por: Yang, Yun, et al.
Publicado: (2023) -
The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
por: Wo, Yu Jun, et al.
Publicado: (2019) -
Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021) -
Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)